Transasia invests INR 50 crore to expand its Sikkim manufacturing plant

Largest Indian plant for the firm, it would be Northeast’s first diagnostics manufacturing facility

0
44
Download PDF

New Delhi: Transasia Bio-Medicals, India’s leading in-vitro diagnostics company, has announced the INR 50 crore investment in the expansion of its manufacturing facility in Sikkim.

The largest of its India manufacturing plants, Sikkim is the fourth one after Mumbai, Daman and Baddi. Also, the first ever diagnostics manufacturing facility in Northeast, the expanded facility will significantly enhance Transasia’s capacity to cater to the growing Indian and overseas market demands. Spread over 2 acres, the state of the art facility can produce 6000+ instruments monthly including the complete range of semi-automated analyzers.

Announcing the new facility, Suresh Vazirani, Chairman and Managing Director, Transasia Bio-Medicals, said, “Sikkim is fast becoming a major hub for healthcare manufacturing with 14 major players already there. Transasia’s new facility will further reinforce this besides providing employment to local youth who otherwise would need to move out of the state for such quality opportunities. With this addition of capacity, we are well placed to deliver to the demand arising from continued growth posted by the company both in Indian and overseas markets.”

Limited access to quality medical infrastructure, including skilled manpower and technologies have been the pain points of over 70% of Indians who live in smaller towns and rural areas. Transasia addresses this through its competitive pricing, which makes diagnostics affordable besides having a sales & service network present nationwide.